# AltaSciences Clinical Los Angeles Inc., Cypress, CA – FDA Inspections

Source: https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822

> Inspection records and compliance data for AltaSciences Clinical Los Angeles Inc. in Cypress, California. 8 FDA inspections on record, 1 Form 483, last inspected June 30, 2022.

---

## Details

- Name: AltaSciences Clinical Los Angeles Inc.
- FEI Number: 3006237846
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY
- Address Line 1: 5630 Cerritos Ave
- City: Cypress
- State: California
- Zip Code: 90630
- Country Name: United States
- Address: 5630 Cerritos Ave, Cypress, California 90630, United States
- Country: United States

## Related Documents

- [FDA Inspection 1174519 - AltaSciences Clinical Los Angeles Inc. - 2022-06-30](https://www.keypedia.com/records/fda_inspections/altasciences-clinical-los-angeles-inc/14797777-2498-4b83-808f-13fa2eb9406e) — classification: No Action Indicated (NAI), source: FDA, date: June 30, 2022
- [FDA Inspection 1144217 - AltaSciences Clinical Los Angeles Inc. - 2021-06-18](https://www.keypedia.com/records/fda_inspections/altasciences-clinical-los-angeles-inc/b7faa979-974a-458f-bf9c-b68918c5e73c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 18, 2021
- [FDA Inspection 1102096 - AltaSciences Clinical Los Angeles Inc. - 2019-09-04](https://www.keypedia.com/records/fda_inspections/altasciences-clinical-los-angeles-inc/b22d52db-143f-4f61-ad80-0bfe472f0313) — classification: No Action Indicated (NAI), source: FDA, date: September 4, 2019
- [483 - AltaSciences Clinical Los Angeles Inc. - 2017-03-24](https://www.keypedia.com/records/483/altasciences-clinical-los-angeles-inc/6591ff29-733e-4e5f-b1fe-5d33ad1f6b14) — source: FDA, date: March 24, 2017
- FDA Inspection 1008799 - AltaSciences Clinical Los Angeles Inc. - 2017-03-24 — source: FDA, date: March 24, 2017
- FDA Inspection 1008784 - AltaSciences Clinical Los Angeles Inc. - 2017-03-24 — source: FDA, date: March 24, 2017
- FDA Inspection 1006299 - AltaSciences Clinical Los Angeles Inc. - 2017-03-24 — source: FDA, date: March 24, 2017
- [FDA Inspection 1005233 - AltaSciences Clinical Los Angeles Inc. - 2017-03-24](https://www.keypedia.com/records/fda_inspections/altasciences-clinical-los-angeles-inc/311733d7-7367-4060-a1ff-bc086c2efb90) — source: FDA, date: March 24, 2017
- FDA Inspection 991331 - AltaSciences Clinical Los Angeles Inc. - 2016-10-14 — source: FDA, date: October 14, 2016

## Related Companies

- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/d0fd36a5-057e-46eb-8fb3-828cd2c27388)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4)
- [Teva Pharmaceuticals USA, Inc](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/16ce5163-b7e9-4f34-adce-197945dc8b53)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Ei LLC](https://www.keypedia.com/companies/ei-llc/88b53134-ac99-4eb2-b709-2a80a826ad7d)
- [Lambda Therapeutic Research Ltd.](https://www.keypedia.com/companies/lambda-therapeutic-research-ltd/e4515c16-4ff4-451a-9d2f-b4b1668eb47c)
- [Actavis Italy Spa A Socio Unico](https://www.keypedia.com/companies/actavis-italy-spa-a-socio-unico/7c4ac702-d647-4c5d-a853-472db165127e)

## Related Officers

- [investigator](https://www.keypedia.com/people/yvonne-lacour-davis/cf2434a3-26fc-4506-9476-ffe1af0db513)